MMP9 and migraine disorder: Results from 26 selected articles showed that glucocorticoids decreased the expression of matrix metalloproteinase-9 (MMP-9), inhibited nitric oxide synthesis, and reduced calcitonin gene-related peptide (CGRP) levels, all of which are key agents implicated in migraine pathogenesis.